Eleonora Cremonini Selected Research

Eleonora Cremonini Research Topics

Disease

10	Inflammation (Inflammations) 03/2024 - 12/2016
10	Insulin Resistance 03/2024 - 01/2016
8	Obesity 02/2024 - 01/2016
5	Type 2 Diabetes Mellitus (MODY) 03/2024 - 01/2018
5	Endotoxemia 01/2023 - 01/2018
4	Necrosis 11/2022 - 05/2015
4	Neoplasms (Cancer) 11/2022 - 05/2015
2	Body Weight (Weight, Body) 02/2024 - 12/2023
2	Hyperlipidemias (Hyperlipidemia) 12/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2022
2	Dysbiosis 01/2020 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2018
2	Overweight 01/2019 - 01/2018
2	Cognitive Dysfunction 02/2014 - 05/2013
1	Hyperglycemia 03/2024
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Fatty Liver 01/2022
1	Viral Pneumonia 01/2022
1	Human Influenza (Influenza) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Coronavirus Infections 03/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Pneumonia (Pneumonitis) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Osteoporosis 01/2016
1	Metabolic Bone Diseases (Osteopenia) 01/2016
1	Hot Flashes 06/2015
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 02/2014
1	Alzheimer Disease (Alzheimer's Disease) 02/2014
1	Bone Resorption 01/2014
1	Disease Progression 01/2014
1	Dementia (Dementias) 05/2013

Drug/Important Bio-Agent (IBA)

10	Catechin (Z 7300)IBA 03/2024 - 05/2015
6	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2016
5	Insulin (Novolin)FDA Link 03/2024 - 01/2016
5	cyanidinIBA 02/2024 - 01/2018
5	Anthocyanins (Anthocyanin)IBA 02/2024 - 08/2017
5	delphinidinIBA 02/2024 - 01/2018
5	LipidsIBA 01/2023 - 01/2018
4	FlavonoidsIBA 03/2024 - 01/2018
4	flavan-3-olIBA 01/2020 - 01/2016
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 01/2018
3	AntioxidantsIBA 02/2014 - 05/2013
2	EnzymesIBA 03/2024 - 01/2023
2	CarbohydratesIBA 01/2023 - 01/2018
2	Oxidants (Oxidizing Agents)IBA 11/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 12/2016
2	EndotoxinsIBA 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2018
2	Uric Acid (Urate)IBA 02/2014 - 05/2013
2	Sulfhydryl Compounds (Thiols)IBA 02/2014 - 05/2013
2	Advanced Oxidation Protein Products (AOPP)IBA 02/2014 - 05/2013
1	Blood Glucose (Blood Sugar)IBA 03/2024
1	SirtuinsIBA 02/2024
1	Triglycerides (Triacylglycerol)IBA 12/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Hormones (Hormone)IBA 01/2023
1	CurcuminIBA 11/2022
1	lardIBA 01/2022
1	MitogensIBA 01/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	AntigensIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2022
1	Nucleic AcidsIBA 03/2021
1	Ellagic AcidIBA 01/2020
1	MucinsIBA 01/2019
1	GlycosidesIBA 01/2019
1	Claudin-1IBA 01/2019
1	OccludinIBA 01/2019
1	marimastatIBA 01/2018
1	ilomastatIBA 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2018
1	acetovanillone (apocynin)IBA 01/2018
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	PalmitatesIBA 01/2018
1	FructoseIBA 01/2018
1	ChemokinesIBA 12/2016
1	procyanidinIBA 12/2016
1	LigandsIBA 01/2016
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2016
1	OsteoprotegerinIBA 01/2016
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2016
1	HomocysteineIBA 02/2014
1	collagen type I trimeric cross-linked peptideIBA 01/2014

Therapy/Procedure

1	Long-Term Care 01/2022
1	Therapeutics 01/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2015